The Doris Duke Innovations in Clinical Research Award provides funding for early-stage research projects in clinical investigation to foster innovations in clinical research that advance the prevention, diagnosis and treatment of human disease.
DDCF seeks proposals for cutting-edge clinical research that has potential to catalyze innovation breakthroughs in sickle cell disease. This award will provide $150,000 per year for three years to support direct research expenses including salary support, plus $12,000 (8 percent) for indirect costs. It is anticipated that up to 10 awards will be made in 2013.
In keeping with the wishes expressed in Doris Duke's will, experiments that use animals or primary tissues derived from animals will not be supported by this program.
Letters of intent are due March 14, 2013 and proposals are due May 13, 2013. The award start date is Sept. 1, 2013.
For complete competition details, visit the Innovations in Clinical Research Award website.